ALLISON HENDERSON: Open Payments
NPI 1215395306 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 49 payments from 11 companies in 2025. Trend: 2023 $576 · 2024 $830 · 2025 $971
Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 14 | $327 |
| Novartis Pharmaceuticals Corporation | 16 | $287 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $87 |
| Abbott Laboratories | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
| AtriCure, Inc. | 1 | $26 |
| Medtronic, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: LEQVIO, WATCHMAN Access System, FARAPULSE, LifeVest, Kerendia, CARDIOMEMS, AMVUTTRA, ACCOLADE SR.
Industry payments across MS — which companies pay providers there.
